ESC Premium Access

Antithrombotic therapy in atrial fibrillation patients undergoing PCI: where do we stand?

Event: ESC CONGRESS 2019
Topic: Atrial Fibrillation (AF)
Session type: Satellite Symposium
Daiichi Sankyo Europe GmbH
Date: 3 September 2019
Time: 13:00 - 14:00

Congress Session

6 presentations in this session

Introduction

Speaker: Professor F. Verheugt (Amsterdam, NL)
Speaker: Doctor M. Lettino (Monza, IT)
Thumbnail

Standard of care and current challenges in patients with atrial fibrillation undergoing percutaneous coronary intervention

Speaker: Doctor M. Lettino (Monza, IT)
Thumbnail

ENTRUST- AF PCI trial

Speaker: Professor A. Goette (Paderborn, DE)
Thumbnail

ENTRUST-AF PCI trial in context with other non-vitamin K antagonist oral anticoagulant trials in percutaneous coronary intervention practice

Speaker: Professor P. Vranckx (Hasselt, BE)
Thumbnail

Panel discussion

Speaker: Professor F. Verheugt (Amsterdam, NL)
Speaker: Doctor M. Lettino (Monza, IT)
Thumbnail

Summary and conclusions

Speaker: Professor F. Verheugt (Amsterdam, NL)
Speaker: Doctor M. Lettino (Monza, IT)
Thumbnail

9 speakers from this session

Professor Freek Verheugt

Onze Lieve Vrouwe Gasthuis, Amsterdam (Netherlands (The))
21 presentations
0 follower

Doctor Maddalena Lettino

San Gerardo Hospital, Monza (Italy)
27 presentations
0 follower

Doctor Maddalena Lettino

San Gerardo Hospital, Monza (Italy)
27 presentations
0 follower

Professor Andreas Goette

Saint Vincenz Hospital Paderborn, Paderborn (Germany)
33 presentations
0 follower

Professor Pascal Vranckx

Heart Centre Hasselt, Hasselt (Belgium)
22 presentations
0 follower

Professor Freek Verheugt

Onze Lieve Vrouwe Gasthuis, Amsterdam (Netherlands (The))
21 presentations
0 follower

Doctor Maddalena Lettino

San Gerardo Hospital, Monza (Italy)
27 presentations
0 follower

Professor Freek Verheugt

Onze Lieve Vrouwe Gasthuis, Amsterdam (Netherlands (The))
21 presentations
0 follower

Doctor Maddalena Lettino

San Gerardo Hospital, Monza (Italy)
27 presentations
0 follower

This platform is supported by

logo Novo Nordisk